พบ "Public health policy"ทั้งหมด 1,272 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
ความเกี่ยวข้อง
Telemedicine Public Reimbursement Models for National and Subnational Jurisdictions: Scoping Review
Background:
Telemedicine has transformed health care delivery, offering improved access, efficiency, and potentially cost-effectiveness. However, wide-scale implementation is challenged due to multiple factors. Among these, reimbursements were reported to influence the scalability and sustainabilit
HIV/AIDS health care challenges for cross-country migrants in low- and middle-income countries: a scoping review (2014)
Rapeepong Suphanchaimat1,2 Angkana Sommanustweechai1 , Chiraporn Khitdee1 , Chompoonut Thaichinda1 , Kanang Kantamaturapoj3 , Pattara Leelahavarong4 , Pensom Jumriangrit1 , Thitikorn Topothai1 , Thunthita Wisaijohn1
Weerasak Putthasri1
1International Health Policy Program (IHPP), Ministry of Publi
Policy Brief: Conducive Factors to HTA Development in Asia
The Health Technology Assessment (HTA), which is a crucial tool for setting health intervention priorities, has been rapidly developing in Asia-Pacific, but is still not fully employed by many countries in policy decision making. Although HTA institutions and networks have been operating successfully in OECD countries and a few of the middle-income
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh (2016)
Background
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li
โครงร่างวิจัย: การศึกษาความคุ้มค่าทางเศรษฐกิจ ของการรักษาเพื่อชะลอการเสื่อมของไต ด้วยการรักษาแบบบูรณาการ (integrated care) ในผู้ป่วยโรคไตเรื้อรัง ระยะ 3-4
In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht f
Center for Global Development launched a report on “Priority-Setting in Health: Building institutions for smarter public spending”
“Health donors, policymakers, and practitioners continuously make life-and-death decisions about which type of patients receive what interventions, when, and at what cost. These decisions—as consequential as they are— often result from ad hoc, nontransparent processes driven more by inertia and inte
The Lancet Commission for Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases
Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d
Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. (2010)
Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences.
Rob Baltussen1, Sitapon Youngkong11,2, Francesco Paolucci3, Louis Niessen4
1 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands
2 Health I
METHODS FOR COST-EFFECTIVENESS ANALYSIS: AN ADVANCED WORKSHOP
Health Intervention and Technology Assessment Program hosted a health economic evaluation workshop, Methods for Cost-Effectiveness Analysis: An Advance Workshop on 28th-30th July 2010 at Richmond Hotel, Nonthaburi, Thailand. This workshop was ru
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
Abstract
BACKGROUND:
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) th
10 / หน้า